Sorrento Therapeutics (SRNE) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Sorrento Therapeutics (SRNE)

0.00

-0.00 (0.00%)

as of Sep 4, 2026, 12:00:00 am Market Open.

8 watching

DON'T BUY

Not a meme stock but it has too much hot money in it.

RISKY

A smaller pharma name. It's a pure spec stock. If you're a young investor, it doesn't hurt to hold one spec stock.

Showing 1 to 2 of 2 entries

Most Recent Experts

Eric Nuttall

Ninepoint Partners

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Kevin Simpson

Capital Wealth Planning

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Sorrento Therapeutics (SRNE) Frequently Asked Questions

What is Sorrento Therapeutics stock symbol?

Sorrento Therapeutics is a American stock, trading under the symbol SRNE (previously SRNE-Q on Stockchase) on the NASDAQ (SRNE). It is usually referred to as NASDAQ:SRNE or SRNE

Is Sorrento Therapeutics a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on SRNE (previously SRNE-Q on Stockchase) on Stockchase. Read the latest expert commentary for Sorrento Therapeutics.

Is Sorrento Therapeutics a good investment or a top pick?

Sorrento Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Sorrento Therapeutics.

Why is Sorrento Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Sorrento Therapeutics.

Is Sorrento Therapeutics worth watching?

Sorrento Therapeutics is followed by 8 investors on Stockchase and is a trending stock that is worth watching.

What is Sorrento Therapeutics stock price?

On 2026-09-04, Sorrento Therapeutics (SRNE) stock closed at a price of $0.00.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Sorrento Therapeutics (SRNE)